A tablet comprising empagliflozin and metformin hydrochloride
Patent Information
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- SANOVEL ILAC SANAYI & TICARET ANONIM SIRKETI
- Filing Date
- 2023-05-25
- Publication Date
- 2026-06-03
AI Technical Summary
Existing formulations of empagliflozin and metformin hydrochloride face challenges due to low solubility and poor compressibility of empagliflozin, and metformin's high amounts causing issues with homogeneity, flowability, and dissolution profile, leading to ineffective tablet formulations.
A film-coated tablet using hydroxypropyl methyl cellulose or hydroxypropyl cellulose as a binder, combined with diluents like corn starch and glidants/lubricants such as anhydrous colloidal silicon dioxide and magnesium stearate, to enhance dissolution profile, flowability, and compressibility, with a wet granulation process for preparation.
The solution provides a tablet with improved pharmacotechnical properties, high bioavailability, long-term stability, and a simple, cost-effective production method, overcoming the limitations of previous formulations.
Smart Images

Figure IMGF000002_0001 
Figure IMGF000003_0001 
Figure IMGF000007_0001